Member Info for bignose58

As I wrote, a handful of shares ;-)

Depends how one looks at it doesn't it ?

If you are only buying a handful of shares, you will get them cheap, but if one had several million which they would have automatically got the rights to, no problem. Try buying several million and see what price you get them for.

Yes, all very true. I really don’t think they will upscale or even consider another manufacturing line (if that is at all possible) before they see demand, although Taiwan etc will also need a supply which even upscaling, I’m sure, still won’t be enough. A bit chicken and egg now given they must be apprehensive based on the original sales figures.

OTC ;-)

Afternoon The.Italian,

I notice both FUM and MHC(testing kits) both have agreements with boots (MHC just announced a new tie up) which, given boots have 2000+ outlets could be quite lucrative. Yet Recordati seems to be dragging their feet. I don’t actually recall any boots tie up when the product was only prescription.

Do you think they may get into some agreement now it’s ?

In the April Op update where the SPA is mentioned, JG mention phase iii studies twice indicating more than 1 is required, which are to start after the EOP2 meeting. As such, I really don’t expect an update till then, unless the SPA leads to a license agreement which I doubt considering the marketing exercise 3 years ago has led to absolutely nuffin either.

It certainly appears they are clutching at straws now looking at ways to convince a licensee to sign, particularly since not one licensee was willing to take a small risk to sign a license supposedly worth many tens of millions.

The.Italian, they are probably the same, although alluding to finishing a phase iii meaning an imminent NDA submission, 3 years ahead of schedule, could be considered, depending who you talk to, as being fraudulent.

Dougie/The.Italian

I suspect the China syndrome is progressing as expected and I am sitting in anticipation of an early call to say they have submitted the NDA, however. The FDA Phase 3 cannot progress without an injection of cash which is why they have gone for the SPA in the hopes it may convince a US licensee to commit, however. Given all the jam tomorrow put out by the company before regarding the FDA approval process, I'm not going to hold my breath and now don't expect approval till more likely the end of 2026/beginning of 2027 (best forgotten about at the moment, what a disaster it has been).

The European income will be next to nothing given the manufacturer is only issuing 30k cans every 3 months which will be sold at around 40Euros/can (180k GBP to ERP based on 15%), so China is the place for me....lol

Interestingly, JG thinks the FDA phase III study is completed, according to the April 17th Operational update.

Jamie Gibson, CEO of the Group, said “We are delighted with these highly significant and positive results from the Phase 3 clinical study in China, which reinforces the results from the European and US Phase 3 clinical studies".

OMG.....:-O they've been lying to us all along !!!

I see DVP has taken off again, up over 7% today. Market cap at around 625mill AU$ now.

Morning The.Italian,

Interestingly I have been following the antics of CTAG over the years who were also delisted. (not sure if you know of them).

Anyway, a lot of disgruntled shareholders since it was delisted about 5 years ago, although I kept watching since the CEO appeared to have gone AWAL and run off with shareholder money. He did manage to get some remaining investors to part with money after the event which made them even more disgruntled. There were also many unsavory characters on the BB, but I wont go into too much detail on them.

What is interesting is CTAG had an all singin', all dancing wrist band that was supposed to tell the wearer all sorts of

health things. Suffice to say it never took off, however. Apparently, the CEO has now supposedly sold the IP for an alleged 275mill squid to some company (the IP actually has some similarities to those of DLI). I'm still watching as the remaining disgruntled shareholders are now hopeful they will see the light at the end of the tunnel. Good luck to them, if they do.

Of interest since the DLI software would seem to be more advanced and could indicate some light at the end of the DLI tunnel.... :-)

The link will work for any company, just replace the PLE ticker with whatever you are looking for

And anyone else who may be interested.

LSE have said "Delisted companies not showing is a temporary glitch that should be resolved soon".

The.Italian try this link:

https://www.lse.co.uk/SharePrice.html?shareprice=PLE

Seems to work. :-)

LSE have said "Delisted companies not showing is a temporary glitch that should be resolved soon".

Try this link: https://www.lse.co.uk/SharePrice.html?shareprice=PLE

Seems to work

Seems there maybe a problem with the PLE BB ?

This is a test.

Afternoon The.Italian,
Well, they have just awarded options to deep longevity employees although I’m not sure why since they still have not sold anything to anyone…….

Yet in the announcement on 29th March 2023 they state.

Based on the FDA's published target review period guidelines which includes time to review the newly provided information, the Board continue to anticipate grant of the De Novo request in Q2 2023.

So, actually anytime from now until the end of June.

Although they have recently employed that local HK director, so maybe not as ominous as I’m alluding to :-)

And you may be right regarding volatility etc given that FUM only has 293mill shares in issue and the sp has not been as volatile as one could expect.

Morning The.Italian,

I appreciate the feedback. It is really difficult to understand what they intend to do but it certainly doesn’t feel right. So much for their ideals of becoming one of the largest pharma companies in HK. In fact it just highlights even more to the locals what a bunch of clowns they truly are.

I wonder if they want to return to their roots as a mining investment company given they may have now realised they are out of their depth regarding pharma…….. lol

And remember, the consolidation after the PLE takeover was only 10:1 from 15 billion shares to 1.5billion, which I consider a more reasonable. Why didn't they consolidate at 20:1 back then when there were 3 times more shares in circulation !!!